AMRN flies on positive tests, C sells widely, CEU staggers

Amarin Corp. PLC (NasdaqCM: AMRN) enjoyed a gain of gained 58.03 percent in price early Monday to $5.61. Volume in the first hour was a staggering 17,200,902 shares, trampling its three-month average share volume of 767,131. The Connecticut and Ireland-based pharmaceutical company today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101.

Citigroup Inc. (NYSE: C) was among Monday morning’s volume leaders, trading in 104,926,884 shares, nearly a quarter of its normal daily volume of 117,592,265 shares, with its three-month average share volume pegged at 464,971,000. The banking behemoth upped its price by 0.97 percent to $4.15. C today announced that it has won a mandate to provide third-party securities lending services for Global X Funds’ family of exchange traded funds.

China Education Alliance Inc. (NYSE: CEU) fell in price early Tuesday by 12.7 percent to $3.85. Volume was 165,878 shares, its three-month average share volume not available at press time. CEU is a leading China-based company experiencing fast-growing, offering high-quality education resources and services to students ages 6 to 18 and adults (university students and professionals) ages 18 and over.

Tags: AMRN, biopharmaceuticals, C, CEU, china stocks, Financial Stocks, nasdaq, NYSE, pharmaceutical stocks

This entry was posted on Monday, November 29th, 2010 at 11:08 am by Glenn and is filed under Financial Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.